0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Mezavant Xl - API Insight, 2022 - Product Thumbnail Image

Mezavant Xl - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Amitiza - API Insight, 2022 - Product Thumbnail Image

Amitiza - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Prilosec - API Insight, 2022 - Product Thumbnail Image

Prilosec - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Gaster D - API Insight, 2022 - Product Thumbnail Image

Gaster D - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Gasmotin - API Insight, 2022 - Product Thumbnail Image

Gasmotin - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Rocephin - API Insight, 2022 - Product Thumbnail Image

Rocephin - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Pentasa Enema - API Insight, 2022 - Product Thumbnail Image

Pentasa Enema - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Pariet - API Insight, 2022 - Product Thumbnail Image

Pariet - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Metgluco - API Insight, 2022 - Product Thumbnail Image

Metgluco - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Tygacil - API Insight, 2022 - Product Thumbnail Image

Tygacil - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Zurcal - API Insight, 2022 - Product Thumbnail Image

Zurcal - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Zosyn - API Insight, 2022 - Product Thumbnail Image

Zosyn - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Invanz - API Insight, 2022 - Product Thumbnail Image

Invanz - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Takepron - API Insight, 2022 - Product Thumbnail Image

Takepron - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Acthar Gel - API Insight, 2022 - Product Thumbnail Image

Acthar Gel - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Aciphex - API Insight, 2022 - Product Thumbnail Image

Aciphex - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Merrem PWS IV- Generic sale global - API Insight, 2022 - Product Thumbnail Image

Merrem PWS IV- Generic sale global - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Unasyn - API Insight, 2022 - Product Thumbnail Image

Unasyn - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Zerbaxa - API Insight, 2022 - Product Thumbnail Image

Zerbaxa - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more